Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
about
Epidemiology and socioeconomic impact of skin disease in lupus erythematosusPenicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.Drug eruptionsNew approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunityArylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityMetabolism of hydralazine: relevance to drug-induced lupusPulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodiesHLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravisPulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremitiesAntibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.Pharmacogenetic perspectives on susceptibility to toxic industrial chemicalsThe genetics and epigenetics of autoimmune diseases.Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond.Acetylator phenotypes in Papua New Guinea.Mechanisms of immune-mediated liver injury.Pharmacogenetics of drug hypersensitivity.Idiosyncratic drug reactions: a mechanistic evaluation of risk factorsCarbamazepine induced systemic lupus erythematosus: case report.HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspectsGenetic factors in the predisposition to drug-induced hypersensitivity reactionsDrug hepatotoxicity.Lupus: an overview of the disease and management options.Hydralazine, antinuclear antibodies, and the lupus syndromeThe epigenetics of autoimmunity.Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro.Joining the DoTS: new approach to classifying adverse drug reactionsThe immunogenetic background of scleroderma--an overview.Drug-induced glomerular disease: immune-mediated injury.Gender differences in autoimmunity associated with exposure to environmental factorsDiseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-EEffect of acute cytomegalovirus infection on drug-induced SLE.Epigenetic mechanisms in lupus.Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.HLA and pharmacogenetics of drug hypersensitivity.Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.Drug-induced rheumatic syndromes. Diagnosis, clinical features and management.Immunogenetically controlled autoimmune reactions induced by mercury, gold and D-penicillamine in laboratory animals: a review from the vantage point of premarketing safety studies.
P2860
Q22299248-7675DC36-5924-4EBD-97DC-63DA6B524BFEQ24514496-C60DA651-0661-40AB-8E5D-B30030A4A078Q24642745-683020BA-F659-427D-99DA-DF484197ED99Q26800973-A0472CD3-CC1E-4AC2-A087-B1075907839FQ26995125-7F7557F3-BE7D-4A4B-85F1-86A19C41DDA5Q27692095-1582F333-3AA7-41E3-BC0E-5AA9BC5C06BBQ28080256-C45B5AFE-6842-44FD-82A8-9609BDFFF27AQ28238389-D2397D95-77F4-4AD0-8560-7901F3D9FB40Q28340697-5EB3A306-7264-442F-AF0A-45AAF8487B31Q28366520-CC8D563D-E6AA-434D-B0FF-78329C40F429Q33556953-219EB0B0-6CDE-4950-8C5F-ADFEA260B36CQ33557343-AADA3582-E7E8-4DDA-AF1F-B6B4BE728FF1Q33557473-27F40D1F-436C-4A61-BCF0-D1C50B922DF2Q33572836-69BF7606-7392-4FC6-BF6C-B36C521106B0Q33642586-31D0B48C-E664-4692-B3C1-74E828E75D80Q33643660-73DF692D-EABD-4815-BD1F-5F7E8248F404Q33670130-9972316D-D8FD-45E8-8ACB-557D562FB032Q33856306-73369F0A-DBFA-4B60-83AF-A4F0177221A6Q34118186-6E515EAF-5EC1-469E-8FEE-6DA9E97BF867Q34403403-5F70AAD5-5691-42C4-A4A1-4A2359A1F274Q34488763-81386F06-130F-44A3-A5B2-36C05B2109E2Q34496483-642D7D67-8EA5-45FD-913D-6111E7D08DB0Q34508545-15069E9B-7B66-412C-B583-E2C8015F2152Q34512476-56DEEF5A-F334-4EC3-B989-9797CE946A43Q34638296-D9BCBAE1-F6D3-4F87-9765-5D13C9C2A28AQ34749535-8EF51D3D-D785-4EE5-A516-9B2158B65173Q34979322-7C47475A-7C8E-4A34-A034-95E921566952Q35202118-83B573EB-C0EE-41C1-9ED1-5F36072A1BC0Q35590133-8B4E778D-FC28-486A-8F41-8FFD78CC598CQ35783473-036AE625-4813-4192-ACE4-1FCF41413881Q35816996-72C81131-F6E4-4ED9-96E1-C2CEC3DDF3AAQ35827986-D593CDB7-9709-4F88-8151-34ED66206F42Q36346467-46887940-BF8D-4B24-A4EB-BFCCD5F1E684Q36679277-9D88F187-D951-468A-87A0-A862EE908DB2Q37284401-2308F5D4-7B83-4C5C-8854-993C1C931ADBQ37611024-7CAB2F19-782C-4C78-9586-59F14B6D1FEAQ38037649-A8557923-9B9B-4C6C-99CF-5781E6522FC4Q38190033-1AE95EB4-661D-4487-87D1-E75A81D170D3Q38217900-F1D06E29-7F1F-4676-AA30-8D04811B56B9Q39682456-01C4C8F0-D990-4987-A051-6DACC36A6DBA
P2860
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
description
1980 nî lūn-bûn
@nan
1980 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@ast
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@en
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@nl
type
label
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@ast
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@en
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@nl
prefLabel
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@ast
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@en
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@nl
P2093
P1433
P1476
Hydralazine-induced systemic l ...... -DR and sex on susceptibility.
@en
P2093
C T Dollery
G I Russell
J R Batchelor
R Bernstein
R M Tinoco
P304
P356
10.1016/S0140-6736(80)91554-8
P407
P577
1980-05-01T00:00:00Z